Seeking Alpha

NGSX
  NeurogesX, Inc. - OTCPK - No Info

10/31/2014, 4:04 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
NGSX vs. ETF Alternatives
Company Description
NeurogesX, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies to address unmet medical needs and improve patients' quality of life.<br /><br />The Company's lead product, Qutenza?, is currently approved... More